Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001641172-25-019801

Options or other derivatives

  • Director acquired 137,078 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Peoples George Director 2025-07-09 Grant or award · Non-Qualified Stock Options (right to buy) +137,078 137,078 D
Loading xslF345X05/ownership.xml…